Because lupus can cause a lot of different health problems, there are many different kinds of medicines that can treat it. You and your doctors can work together to find the right combination of ...

Fresh off of a European approval for a subcutaneous version of Saphnelo, AstraZeneca is doubling down on the benefits of the ...

Lupus is often marked by flares, which is when symptoms are usually more obvious.

Lupkynis™ (voclosporin) was approved by the U.S. Food and Drug Administration (FDA) to treat adults with lupus nephritis in January 2021. Lupus nephritis is a type of kidney disease caused by ...

Phase 3 trial data show subcutaneous anifrolumab improves BICLA response rates and reduces oral corticosteroid use in systemic lupus erythematosus.

Lupus is a disease long-plagued by failed clinical trials. And hopeful patients, many of them young women of color, are waiting — just three lupus drugs have been approved by the Food and Drug ...

Which of the statements about the 2025 American College of Rheumatology guideline for the treatment of systemic lupus ...

Lupus affects women at disproportionately high rates— roughly 9 out of 10 patients are female —and research consistently ...

Today, the Lupus Research Alliance, the world's largest private funder of lupus research, announced the formation of a new philanthropic venture fund Lupus Ventures. The Fund is dedicated to advancing ...

Steroids are a common treatment for lupus, but they can contribute to weight gain. Being overweight poses greater health risks for women with lupus. Selena Gomez said her lupus medication causes her ...